- Original article
- Open Access
Evaluation of the questionnaires’ validity in assessing the severity of idiopathic pulmonary fibrosis in correlation with high-resolution computed tomography, lung diffusion, and cardiopulmonary exercise tests
Egyptian Journal of Bronchology volume 11, pages 141–148 (2017)
Health-related quality-of-life questionnaires need to be incorporated into the evaluations of idiopathic pulmonary fibrosis (IPF) patients to assess their influence.
The aim of the study was to evaluate the validity of generic and specific questionnaires in assessing the severity of IPF in correlation with high-resolution computed tomography (HRCT), diffusion lung capacity for carbon monoxide (DLCO), and cardiopulmonary exercise testing (CPET).
Patients and methods
Forty stable IPF patients were prospectively recruited and categorized on the basis of spirometry, DLCO, HRCT, and CPET. The results were correlated with a generic International Physical Activity Questionnaire (IPAQ) and a Specific Saint George Respiratory Questionnaire (SGRQ).
IPF patients showed restrictive pattern with impairment of diffusion capacity (forced vital capacity (FVC)= 56±14.8% and DLCO=48.5±20% of predicted value) with a total semiquantitative scoring of HRCT 16.6±8. The mean total score of the SGRQ questionnaire for all studied cases was 56.5+21 and categorical scoring of IPAQ showed that 45, 42.5, and 12.5% of patients were in moderate, severe, and mild categories, respectively. There was a negative correlation between the total score of SGRQ and VO2max (ml/kg/min) (maximum oxygen consumption) (r=−0.35) and VE’ (l/min) (minute ventilation) (r=−0.39) on CPET, as well as with DLCO (r=−0.53), and a positive correlation with HRCT score (r=0.63). There was a highly significant correlation between IPAQ and VO2max (χ2=28), VE’ (χ2=14.8) and desaturation percentage variables of CPET, DLCO (r=0.61), and HRCT score (r=−0.68).
Correlations between physiological parameters including DLCO and CPET, radiological parameters in the form of HRCT, and health-related quality-of-life assessment using SGRQ and IPAQ were strong and it was possible to distinguish IPF patients with severely impaired lung functions.
Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174:810–816.
Webb WR, Muller ML, Naidich DP. High-resolution CT of the lung. Philadelphia, USA: Lippincott Williams & Wilkins; 2001. p. 196.
Zimmermann CS, Carvalho CF, Silveira KR, Yamaguti WP, Carvelho CR. Comparison of two questionnaires which measure the health-related quality of life of idiopathic pulmonary fibrosis patients. Braz J Med Biol Res 2007; 40:179–187.
American Thoracic Society. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788–824.
Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. ATS/ERS Task Force: standardisation of lung function testing. General considerations for lung function testing. Eur Respir J 2005; 26:153–161.
Ooi GC, Mok MY, Tsang KW, Wong Y, Khong PL. Interstitial lung disease in systemic sclerosis. Acta Radiol 2003; 44:258–264.
American Thoracic Society/American College of Chest Physicians. ATS/ ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167:211–277.
Wasserman K, Hansen J, Sue D, Stringer W, Whipp B. Principles of exercise testing and interpretation. 4th ed. Philadelphia, USA: Lippincott Williams & Wilkins; 2004. 25–30.
Jones PW, Quirk FH, Baveystock CM. The St George’s Respiratory Questionnaire. Respir Med 1991; 85:25–31.
Booth ML. Assessment of physical activity: an international perspective. Res Q Exerc Sport 2000; 71:s114–s120.
Martinez TY, Pereira CA, Santos ML, Ciconelli RM, Guimaraes SM, Martinez JA. Evaluation of short form36 itemquestionnaire to measure health related quality of life in patients with IPF. Chest 2000; 117:1627–1632.
de Vries J, Seebregts A, Drent M. Assessing health status and quality of life in idiopathic pulmonary fibrosis: which measure should be used? Respir Med 2000; 94:273–278.
Chang JA, Curtis JR, Patrick DL, Raghu G. Assessment of health related quality of life in patients with interstitial lung disease. Chest 1999; 116:1175–1182.
Fishbein MC. Diagnosis: to biopsy or not to biopsy; assessing the role of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis. Chest 2005; 128(Suppl 1):520S–525S.
Blivet S, Philit F, Sab JM, Langevin B, Paret M, Guérin C, et al. Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. Chest 2001; 120:209–212.
Peng S, Li Z, Kang J, Hou X. Cross-sectional and longitudinal construct validity of the Saint George’s Respiratory Questionnaire in patients with IPF. Respirology 2008; 13:871–879.
Wensel R, Opitz CF, Ewert R. Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension. Circulation 2000; 101:2388–2392.
Beretta L, Santaniello A, Lemos A, Masciocchi M, Scorza R. Validity of the Saint George’s Respiratory Questionnaire in the evaluation of the HRQL in patients with interstitial lung disease secondary to systemic sclerosis. Rheumatology 2006; 36:1–6.
Nogueira I, Servantes D, Nogueira P, Pelcerman A, Salvetti X, Salles F, et al. Correlation between quality of life and functional capacity in cardiac failure. Arq Bras Cardiol 2010; 95:2.
Chou CL, Chang CL, Hung SY, Lee SH, Lee CS, Huang CM, et al. The relationship between peak oxygen consumption and quality of life in patients with rheumatoid arthritis. Formos J Rheumatol 2008; 22: 74–79.
Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the International Physical Activity Questionnaire short form (IPAQ-SF): a systematic review. Int J Behav Nutr Phys Act 2011; 8:115.
Beretta L, Santaniello A, Lemos A, Masciocchi M, Scorza R. Validity of the Saint George’s Respiratory Questionnaire in the evaluation of the health related quality of life in patients with interstitial lung disease. Rheumatology 2007; 46:296–301.
Swigris JJ, Gould MK, Wilson SR. Health-related quality of life among patients with idiopathic pulmonary fibrosis. Chest 2005; 127: 284–294.
Tzanakis N, Samiou M, Lambiri I, Antoniou K, Siafakas N, Bouros D. Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur J Intern Med 2005; 16:105–112.
Vries J, Kessels BL, Drent M. Quality of life of idiopathic pulmonary fibrosis patients. Eur Respir J 2001; 17:954–961.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms.
About this article
Cite this article
El Naggar, T., Said, A.M., Sharkawy, S.H. et al. Evaluation of the questionnaires’ validity in assessing the severity of idiopathic pulmonary fibrosis in correlation with high-resolution computed tomography, lung diffusion, and cardiopulmonary exercise tests. Egypt J Bronchol 11, 141–148 (2017). https://doi.org/10.4103/1687-8426.203798
- cardiopulmonary exercise test
- diffusion lung capacity for carbon monoxide
- International Physical Activity Questionnaire
- interstitial pulmonary fibrosis
- Saint George Respiratory Questionnaire